Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar
FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar
FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar
Submitted by
admin
on September 8, 2017 - 9:28am
Source:
RAPS.org
News Tags:
FDA
Celltrion
biosimilars
Pfizer
Inflectra
Remicade
Headline:
FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar
Do Not Allow Advertisers to Use My Personal information
